Medicare Enrolled
Dr. Peyman Ghasri, M.D.
Optician · Encino, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ghasri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ghasri?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ghasri
Dr. Peyman Ghasri is an optician specialist in Encino, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ghasri performed 19,683 Medicare services across 6,488 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ghasri received a total of $13,569 from 57 pharmaceutical and/or device companies across 696 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ghasri is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 5% volume in CA
$13,569 industry payments
Medicare Practice Summary
Medicare Utilization ↗19,683
Medicare services
Top 5% in CA for optician
6,488
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,036 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
8,434 | $6 | $10 |
| Puraply AM application per square centimeter Application of Puraply AM dressing to the skin. The charge is calculated based on the surface area treated. |
2,945 | $83 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,714 | $112 | $211 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
1,153 | $98 | $185 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
1,015 | $39 | $116 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
762 | $80 | $158 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
699 | $65 | $160 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
480 | $155 | $234 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
411 | $98 | $194 |
| Destruction of skin growth, 15 or more growths | 248 | $120 | $189 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
211 | $47 | $91 |
| Skin substitute graft application, 25 sq cm or less Application of a skin substitute graft to a wound on the face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes. The wound area covered is 25.0 square centimeters or less. |
161 | $131 | $407 |
| Skin growth removal and lab exam, 1-5 blocks This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory. |
152 | $375 | $1,200 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 143 | $378 | $1,200 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
135 | $109 | $200 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
79 | $306 | $700 |
| Complicated wound repair of trunk, 2.6-7.5 cm A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length. |
78 | $357 | $521 |
| Complex or multiple skin abscess drainage A procedure to drain one or more skin abscesses that are complex in nature. This involves opening and cleaning the infected pockets under the skin. |
74 | $192 | $290 |
| Injection into skin growths, more than 7 A procedure involving the injection of medication into more than seven skin growths. |
72 | $51 | $125 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
71 | $34 | $85 |
| Skin growth removal and lab exam, 1-5 blocks A procedure to remove a growth from the trunk, arms, or legs and send 1 to 5 tissue samples to a laboratory for microscopic examination. |
69 | $434 | $1,200 |
| Additional Mohs surgery stage with microscopic exam This procedure involves the removal and microscopic examination of an additional stage of tissue from the trunk, arms, or legs. It is performed in stages to ensure complete removal of the growth. |
63 | $365 | $600 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
58 | $1 | $29 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
45 | $142 | $210 |
| Skin graft for scalp, arm, or leg wound, 10.1-30 sq cm This procedure involves repairing a wound on the scalp, arms, or legs by transferring skin from another area to cover the defect. The graft size is between 10.1 and 30.0 square centimeters. |
42 | $780 | $1,200 |
| Eyelid biopsy A procedure to remove a small sample of tissue from the eyelid for laboratory examination. |
42 | $164 | $250 |
| Skin graft repair, 10.1-30 sq cm A surgical procedure to repair wounds on the forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin. The graft covers an area between 10.1 and 30.0 square centimeters. |
41 | $829 | $1,400 |
| Removal of noncancer skin growth, 2.1-3.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The excised tissue measures between 2.1 and 3.0 centimeters in diameter. |
34 | $90 | $350 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
33 | $79 | $250 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
33 | $62 | $171 |
| Skin graft repair, 10 sq cm or less A surgical procedure to repair a wound by transferring a small piece of skin to the affected area. The graft covers wounds on the face, neck, hands, feet, or other specified body parts. |
31 | $680 | $1,200 |
| Complicated wound repair, 2.6-7.5 cm A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet. |
26 | $422 | $700 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
23 | $127 | $500 |
| Skin graft repair of eyelid, nose, ear, or lip, 10 sq cm or less A surgical procedure to repair a wound on the eyelid, nose, ear, or lip by transferring a small piece of skin. The transferred skin covers an area of 10 square centimeters or less. |
22 | $637 | $1,200 |
| Removal of noncancer skin growth, 3.1-4.0 cm This procedure involves the surgical removal of a benign skin growth measuring between 3.1 and 4.0 centimeters on the body, arms, or legs. |
17 | $102 | $400 |
| Lip biopsy A procedure to remove a small sample of tissue from the lip for laboratory examination. |
17 | $99 | $200 |
| Removal of noncancer skin growth, face/ears/eyelids/nose/lips/mouth, 2.1-3.0 cm This procedure involves the surgical removal of a benign skin growth from the face, ears, eyelids, nose, lips, or mouth. The growth removed measures between 2.1 and 3.0 centimeters in diameter. |
13 | $104 | $300 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
13 | $65 | $165 |
| Removal of noncancer skin growth, 2.1-3.0 cm This procedure involves the surgical removal of a benign skin growth from the scalp, neck, hands, feet, or genitals. The excision size is between 2.1 and 3.0 centimeters. |
12 | $93 | $300 |
| Skin graft repair of eyelid, nose, ear, or lip, 10.1-30 sq cm This procedure involves repairing a wound on the eyelid, nose, ear, or lip by transferring skin from another area. The graft size covered is between 10.1 and 30.0 square centimeters. |
12 | $895 | $1,500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
6.1% medium
93.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,569
Total received (2018-2024)
Avg $1,938/year across 7 years
Top 11% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
696
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,489 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$80 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,691
2023
$2,579
2022
$1,892
2021
$2,405
2020
$1,437
2019
$1,311
2018
$1,253
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$472
Janssen Biotech, Inc.
$268
Incyte Corporation
$242
GENZYME CORPORATION
$211
Dermavant Sciences, Inc.
$205
Regeneron Healthcare Solutions, Inc.
$199
SUN PHARMACEUTICAL INDUSTRIES INC.
$140
Arcutis Biotherapeutics, Inc.
$116
Amgen Inc.
$109
Lilly USA, LLC
$88
Galderma Laboratories, L.P.
$84
MAYNE PHARMA COMMERCIAL LLC
$73
PFIZER INC.
$66
Journey Medical Corporation
$66
Organogenesis Inc.
$65
Boehringer Ingelheim Pharmaceuticals, Inc.
$59
UCB, Inc.
$57
LEO Pharma Inc.
$35
Novartis Pharmaceuticals Corporation
$31
Verrica Pharmaceuticals Inc.
$23
Krystal Biotech Inc
$21
E.R. Squibb & Sons, L.L.C.
$21
Almirall LLC
$21
Ortho Dermatologics, a division of Bausch Health US, LLC
$18
Top 3 companies account for 36.5% of 2024 payments
All-time payments by company (2018-2024) ›
Galderma Laboratories, L.P.
$1,087
ABBVIE INC.
$1,070
GENZYME CORPORATION
$878
Regeneron Healthcare Solutions, Inc.
$814
AbbVie Inc.
$784
LEO Pharma Inc.
$774
Incyte Corporation
$730
Janssen Biotech, Inc.
$645
MERZ NORTH AMERICA, INC.
$644
PFIZER INC.
$561
Sun Pharmaceutical Industries Inc.
$516
Amgen Inc.
$484
Ortho Dermatologics, a division of Bausch Health US, LLC
$407
Dermavant Sciences, Inc.
$343
SUN PHARMACEUTICAL INDUSTRIES INC.
$298
AbbVie, Inc.
$256
Lilly USA, LLC
$251
Arcutis Biotherapeutics, Inc.
$246
Journey Medical Corporation
$242
Allergan Inc.
$206
Merz North America, Inc.
$159
Almirall LLC
$153
MAYNE PHARMA COMMERCIAL LLC
$151
Biofrontera Inc.
$148
Mayne Pharma Inc.
$148
SANOFI-AVENTIS U.S. LLC
$144
MAYNE PHARMA INC.
$133
Novartis Pharmaceuticals Corporation
$106
EPI Health, LLC
$99
E.R. Squibb & Sons, L.L.C.
$96
Allergan, Inc.
$93
Boehringer Ingelheim Pharmaceuticals, Inc.
$87
Organogenesis Inc.
$65
Celgene Corporation
$64
Mylan Pharmaceuticals Inc.
$59
UCB, Inc.
$57
Aclaris Therapeutics, Inc.
$54
ORGANOGENESIS INC.
$45
DUSA Pharmaceuticals, Inc.
$43
Genentech USA, Inc.
$42
Integra LifeSciences Corporation
$40
Taro Pharmaceuticals USA, Inc.
$34
DERMIRA, INC.
$34
Paratek Pharmaceuticals, Inc.
$33
Medtronic Vascular, Inc.
$29
Osiris Therapeutics Inc.
$27
Pierre Fabre Pharmaceuticals, Inc.
$24
Verrica Pharmaceuticals Inc.
$23
Krystal Biotech Inc
$21
Sandoz Inc.
$21
Solta Medical, a division of Bausch Health US, LLC
$19
Merck Sharp & Dohme Corporation
$17
Sebela Pharmaceuticals Inc.
$15
Helsinn Therapeutics (U.S.), Inc.
$14
iCAD, Inc
$14
NOVARTIS PHARMACEUTICALS CORPORATION
$12
Nabriva Therapeutics, plc
$12
Top 3 companies account for 22.4% of all-time payments
Associated products mentioned in payments ›
0.25% · 20% · ABSORICA · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AXXENT SURFACE CONTROLLER · Absorica LD · Ameluz · BLU-U · BOTOX · BOTOX COSMETIC · BRYHALI · Bimzelx · CLODERM · COSENTYX · CYGNUS DUAL · Cabtreo · Ceracade · Clindamycin Phosphate and Benzoyl Peroxide · DORYX · DUOBRII · DUPIXENT · DYSPORT · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Erivedge · FINACEA · GRAFIX/GRAFIXPL/STRAVIX · HUMIRA · Humira · ILUMYA · Ilumya · Integra · JUBLIA · JUBLIA EFINACONAZOLE · LEVULAN KERASTICK · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · NAFTIN · NUZYRA · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Otezla · Puraply Antimicrobial · QBREXZA · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Seysara · Sitavig · Sivextro · Skyrizi · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · Tremfya · ULTRAVATE (halobetasol propionate) lotion · VALCHLOR · VTAMA · VYJUVEK · VenaSeal · Winlevi · XEOMIN · Xeomin · Xolegel · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
1,270
Per 100K population
12.9
County median income
$87,760
Nearest hospital
ENCINO HOSPITAL MEDICAL CENTER
1.7 mi
1.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ghasri is a clinical cardiology specialist, with above-average Medicare volume (top 5% in CA), with low-engagement industry engagement in the top 11% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ghasri experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Ghasri performed 8,434 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ghasri receive payments from pharmaceutical companies?
Yes. Dr. Ghasri received a total of $13,569 from 57 companies across 696 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ghasri's costs compare to other opticians in Encino?
Dr. Ghasri's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ghasri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Encino
Browse opticians in Encino ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Galderma Laboratories, L.P. Payments to Doctors
See all physicians who received payments from Galderma Laboratories, L.P.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology